Literature DB >> 6172027

Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.

A O Aasen, N S Erichsen, M J Gallimore, E Amundsen.   

Abstract

Components of the plasma kallikrein-kinin system were determined in plasma samples from ten healthy subjects and eight patients with septic shock. Five of the patients died. Low levels of Hageman factor, prekallikrein, and high molecular weight kininogen, together with significantly reduced concentrations of alpha 2-macroglobulin, were observed during septic shock both in patients who died and in the survivors. The patients who died also revealed a pronounced reduction of functional kallikrein inhibition determined by a chromogenic peptide substrate assay. In the survivors, however, functional kallikrein inhibition was very well preserved during septic shock, being within the range of values found in normals. Also plasma prekallikrein and C1-esterase inhibitor levels were slightly higher in the survivors than in those who died. Our results confirm that the plasma kallikrein-kinin system becomes activated during septicemia and that consumption of components of this protease system occurs. Because both C1-esterase inhibitor concentrations and functional kallikrein inhibitory activities were higher in patients who survived septic shock than in the fatal cases, our results suggest that functional inhibition of plasma kallikrein appears to play a major role in the outcome of this condition.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6172027

Source DB:  PubMed          Journal:  Adv Shock Res        ISSN: 0195-878X


  9 in total

Review 1.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

2.  Contact phase of blood coagulation in cardiogenic pulmonary oedema (CPO) and adult respiratory distress syndrome (ARDS).

Authors:  C Herrera; F Velasco; A Guerrero; R Guerrero; F Alvarez; A Torres
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

3.  Cleavage of plasma high molecular weight kininogen in surgical ICU patients.

Authors:  T S Karlsrud; L Buø; A O Aasen; H T Johansen
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

Review 4.  Multiple systems failure and circulatory support.

Authors:  A E Baue; D Guthrie
Journal:  Jpn J Surg       Date:  1983-03

5.  Proteolytic inactivation of plasma C1- inhibitor in sepsis.

Authors:  J H Nuijens; A J Eerenberg-Belmer; C C Huijbregts; W O Schreuder; R J Felt-Bersma; J J Abbink; L G Thijs; C E Hack
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

6.  Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model.

Authors:  J P de Boer; A A Creasey; A Chang; J J Abbink; D Roem; A J Eerenberg; C E Hack; F B Taylor
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

7.  Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

8.  Complement C1 esterase inhibitor levels linked to infections and contaminated heparin-associated adverse events.

Authors:  Zhao-Hua Zhou; Trina Chen; Kamalpreet Arora; Kenneth Hyams; Steven Kozlowski
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

9.  Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system.

Authors:  Shannon L Taylor; Victoria Wahl-Jensen; Anna Maria Copeland; Peter B Jahrling; Connie S Schmaljohn
Journal:  PLoS Pathog       Date:  2013-07-18       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.